ZNF213-AS1

Across TCGA pan-cancer cohorts, ZNF213-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated ZNF213-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ZNF213-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ZNF213-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, ACC, and KIRC are the cancer types where ZNF213-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	II,III,IV	0.700	0.518	<.001	103	view →
ACC	DFS	Tertile	All	0.339	0.759	<.001	69	view →
KIRC	DFS	Median	II,III,IV	0.442	0.599	.006	34	view →
HNSC	OS	Tertile	II,III,IV	0.822	0.698	.011	26	view →
LIHC	DFS	Tertile	All	0.464	0.644	<.001	26	view →
LUAD	DFS	Median	IV	0.406	0.817	.007	22	view →
BRCA	DFS	Median	IV	0.734	0.396	.022	19	view →
THYM	DFS	Median	All	0.941	0.793	.005	18	view →
PRAD	DFS	Median	All	0.700	0.879	.001	18	view →
LGG	OS	Tertile	All	0.529	0.354	.001	16	view →
SKCM	OS	Quartile	III,IV	0.227	0.732	<.001	14	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.266	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

ZNF213-AS1–BLCA (OS)

Open the BLCA breakdown →